Mechanistic profiling of the cAMP-dependent steroidogenic pathway in the H295R endocrine disrupter screening system:

Caroline Vanparys1, Tine L M Hectors, Ronny Blust

  • 1Laboratory of Ecophysiology, Biochemistry and Toxicology, University of Antwerp, Groenenborgerlaan 171, B-2020 Antwerp, Belgium. caroline.vanparys@ua.ac.be

Toxicology Letters
|November 15, 2011
PubMed

Insights

The H295R cell line effectively models the ACTH/cAMP signaling cascade for steroidogenesis, offering a comprehensive platform for endocrine disruption screening. Its gene expression patterns reveal coordinated cholesterol and steroid pathways, crucial for understanding hormone regulation.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Toxicology

Background:

  • Endocrine disruptive compounds require robust screening methods.
  • The H295R cell line is OECD-validated for hormone profiling.
  • Understanding cAMP pathway regulation in steroidogenesis is critical.

Purpose of the Study:

  • To investigate the gene expression profiles of the cAMP response pathway in H295R cells.
  • To elucidate the complete mechanisms and endocrine responsiveness of the H295R cell system.
  • To assess the suitability of H295R cells for omics-based endocrine disruption screening.

Main Methods:

  • Microarray-based gene expression profiling of H295R cells.
  • Analysis of cAMP response pathway and broader lipid metabolic pathways.
  • Transcription network analysis to identify key regulatory factors.

Main Results:

  • cAMP stimulation affects steroid synthesis, lipid metabolism, and hormone receptors in H295R cells.
  • Gene expression is dose and time-dependent, with early regulation of cholesterol genes and later steroid synthesis genes.
  • HNF4α identified as a potential key transcription factor in steroid hormone regulation.

Conclusions:

  • H295R cell gene expression patterns accurately reflect in vivo ACTH/cAMP signaling in adrenal cells.
  • The H295R cell line demonstrates completeness in steroidogenic pathways for omics-based screening.
  • H295R cells are a promising tool for endocrine disruption screening due to their sensitivity and comprehensive pathway representation.